Home » Topics » Regulatory » Patents

Patents
RSS

Cortexyme discloses Porphyromonas gingivalis RgpB inhibitors

Oct. 7, 2020

Chiba Prefecture patents new compounds targeting mitochondrial DNA mutations

Oct. 7, 2020

NuvoBio patents N-lysine methyltransferase KMT5A inhibitors

Oct. 6, 2020

Central China Normal University synthesizes new TRK inhibitors

Oct. 6, 2020

Kyushu University presents new lysosomal alpha-glucosidase inhibitors

Oct. 6, 2020

Hangzhou Innogate Pharma discovers ALK/mutant EGFR/MAP4K1 inhibitors

Oct. 6, 2020

New JAK inhibitors identified at Beijing Scitech-Mq Pharmaceuticals

Oct. 6, 2020

Lead Discovery Center and SOTIO patent new compounds for cancer

Oct. 5, 2020

New ENPP1 inhibitors presented by Stingray Therapeutics

Oct. 5, 2020

Merck & Co. identifies new HDAC inhibitors

Oct. 5, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...